Marker Therapeutics Inc (MRKR)

[hanscott]

I see MRKR had some VERY cool new data presented last week at the ISCT Annual Meeting.

Specifically, the new > Long Term < culture system developed by MRKR that revolutionizes in vitro studies of T Cell interactions with 3D tumors.

Between that and MRKR's newly developed automated, closed T Cell purification system, I understand better the $8-9 million deal between MRKR and Wilson Wolf last month. The deal in which John Wilson, CEO of Wilson Wolf and co-founder of MRKR said will " enhance our effort to de-risk the cell and gene therapy industry as a whole.”
------------------------------------------

Institutions are starting to report 1st Q holdings. The early Nasdaq data shows that two institutions sold out, 3 added to their positions, and 10 made no change.
------------------------------------------

Micro: I read your post - you are correct my friend. It's not worth responding to the constant whimpers and moans. Especially when it's clear that they don't understand the science and that they are surprised to find that there is competition.